Oxygen is needed by all cells throughout the body and so it is natural to consider possibilities for TheraCell's oxygen technology outside of orthopaedics. We started investigating the application of our technology in wound care at the suggestion of some of our advisors and have generated some interesting results. There is a recognized need for devices, such as implants and dressings, with increased oxygen content and other active ingredients to stimulate healing, especially in cases of wounds in patients with diabetes mellitus, venous deficiencies, compromised arterial perfusion, or local tissue hypoxia. Non-healing wounds affect 6 million people in the United States alone, resulting in more than $3 billion per year in health care costs. The wound dressing research will combines all of TheraCell's core technologies, including TheraCell's patented demineralized bone fiber technology for providing a biological scaffold. In use the dressing generates oxygen which is transported through the dressing to the wound.
In February 2018 TheraCell announced that it was awarded a grant from the National Institute of Nursing Research (NINR) of the United States Department of Health and Human Services National Institutes of Health (NIH) to develop an oxygenated wound dressing.